References
- Chuang YC, Chang WN, Lu CH, Wu HS, Chang HW. Pseudomonas aeruginosa central nervous system infections: analysis of clinical features of 16 adult patients. Chung Hua I Hsueh Tsa Chih (Taipei) 1999; 62 (5): 300–307.
- Saez-Llorens X, McCracken GH. Bacterial meningitis Infect Dis Clin North Am 1999; 13 (3): 619-636.
- Schmutzhard E, Williams KJ, Vukmirovits G, Chmelik V, Pfausler B, Featherstone A. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. J Antimicrob Chemother 1995; 36 (Suppl A): 85-97.
- Jorgensen JH, Maher LA, Howell AW. Activity of meropenem against antibiotic-resistant or infrequently encoun-tered gram-negative bacilli. Antimicrob Agents Chemother 1991; 35: 2410–2414.
- Donnelly JP, Horrevorts AM, Sauerwein RW, DePauw BE. High dose meropenem in meningitis due to Pseudomonas aeruginosa. Lancet 1992; 339 (8801): 1117.